2024 financial statements approved
Final dividend of 1.2 eurocents per ordinary share
Approval of Section I and favourable opinion on Section II of the Remuneration Report
Approval of plan for purchase and disposal of ordinary Company shares
Milan, 29 April 2025 – The Annual General Meeting of Immsi S.p.A. shareholders was held today on first call, in ordinary session. It was chaired by Matteo Colaninno and attended by 62.839% of the share capital.
The Meeting examined and unanimously approved the Immsi S.p.A. 2024 separate financial statements and took note of the Immsi Group consolidated financial statements as at and for the year ended 31 December 2024 and the consolidated sustainability report at 31 December 2024.
In 2024, Immsi Group consolidated net sales amounted to 1,748.4 million euro, with EBITDA of 271.1 million euro and an EBITDA margin of 15.5%, its best result ever. Net profit was 29.6 million euro including minority interests of 23.5 million euro. Immsi Group net financial debt at 31 December 2024 was 947.3 million euro. Immsi Group capital expenditure in 2024 amounted to 204.8 million euro.
The Meeting approved the allocation of the profit for the year: (i) 433,208.09 euro to the legal reserve; (ii) 739,293.70 to “Profit (loss) carried forward”; (iii) an overall maximum amount of 4,086,360.00 euro to the shareholders as the final dividend, for an amount of 1.2 eurocents, pre-tax, to each entitled ordinary share (in addition to the interim dividend of 1 eurocent paid on 20.11.2024, ex-dividend date 18.11.2024), for a total dividend for 2024 of 2.2 eurocents.
The ex-dividend date (coupon no. 18) is 19.05.2025, the record date is 20.05.2025 and the payment date is 21.05.2025.
The Meeting also approved the remuneration policy for 2024 pursuant to art. 123-ter, para. 3-bis, of the Consolidated Finance Act (TUF) set out in Section I of the “Report on remuneration policy and fees paid” drawn up pursuant to art. 123-ter of the TUF. Finally, the Shareholders expressed themselves in favour of Section II of the Report pursuant to art. 123-ter, para. 6, of the TUF.
The Immsi S.p.A. Shareholders’ Meeting also renewed the authorisation for the purchase and disposal of the Company’s own shares. The purpose is to provide the Company with a useful strategic investment opportunity for the purposes allowed under law, including the purposes contemplated in art. 5 of EU Regulation 596/2014 (Market Abuse Regulation, hereinafter “MAR”) and in compliance with the practices allowed under art. 13 MAR and the related measures adopted by the national authority, and also for purchases of own shares for subsequent cancellation.
The share buyback authorisation was granted for a maximum number of shares that, taking into account the Immsi S.p.A. ordinary shares held from time to time by the company and the subsidiaries, may not exceed the maximum limit established by the applicable laws in force at the time, and for a consideration that does not exceed the greater of the price of the most recent independent transaction and the price of the highest current independent offer on the trading markets where the buyback is made, subject to the condition that the per-share purchase consideration shall not in any case be more than 20% below and 10% above the mean official share price in the 10 trading days before each purchase transaction.
The purchase authorisation will remain in effect for 18 months as from the date of the AGM, while the authorisation for disposal was granted without any time limit.
As of today, the company does not hold any own shares.
For further information on the resolutions carried by today’s AGM, reference should be made to the reports posted on the Company website (Governance/General Meeting) and to the minutes of the meeting, which will be published as required by law.